Schizophrenia Treatment Adherence Investigation (STAI)
NCT01001481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2014-04-09
Summary
The primary objective of this treatment review and feedback program is to quantify the risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia.
Conditions
- Schizophrenia
- Schizoaffective Disorder
Interventions
- OTHER
-
Risk status for medication adherence
Examination of risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia
Sponsors & Collaborators
-
Janssen-Cilag Pty Ltd
lead INDUSTRY
Principal Investigators
-
Janssen-Cilag Pty Ltd Clinical Trial · Janssen-Cilag Pty Ltd
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
More Related Trials
-
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 ·Status: COMPLETED ·Phase: NA
-
Patient-Centered Medication Adherence Intervention for Schizophrenia
NCT00144027 ·Status: COMPLETED ·Phase: NA
-
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?
NCT00223522 ·Status: COMPLETED
-
Medication Adherence in Older Adults With Serious Mental Illness
NCT00224380 ·Status: COMPLETED ·Phase: NA
-
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
NCT00057135 ·Status: COMPLETED ·Phase: NA
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN
-
A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
NCT07225712 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
NCT04022577 ·Status: COMPLETED ·Phase: NA
-
Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients
NCT01729572 ·Status: UNKNOWN ·Phase: NA
-
A Study of Strategies to Improve Schizophrenia Treatment
NCT00156637 ·Status: COMPLETED ·Phase: NA
-
Compensatory Cognitive Training For Schizophrenia
NCT04040998 ·Status: COMPLETED ·Phase: NA
-
CAE for Poorly Adherent Individuals With Schizophrenia
NCT06061952 ·Status: COMPLETED ·Phase: NA
-
Sustainable Early Episode Clinic Study (SEEC)
NCT03571685 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
Increasing Medication Check Participation Through Applying CT-r
NCT06231407 ·Status: COMPLETED ·Phase: NA
-
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
NCT00873249 ·Status: COMPLETED
-
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.
NCT00392249 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers
NCT00392236 ·Status: COMPLETED ·Phase: NA
-
A Smartphone App on Medication Adherence
NCT05892120 ·Status: UNKNOWN
-
Effects of Atomoxetine on Cognitive Function in Schizophrenia
NCT00420498 ·Status: COMPLETED ·Phase: PHASE2
-
Financial Incentives to Improve Acceptance of Antipsychotic Injections
NCT03192631 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01095562 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
NCT00018837 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan
NCT05359081 ·Status: TERMINATED ·Phase: PHASE3